QBI-139

· Quintessence Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QBI-139, covering 2015-01-28 to 2015-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of QBI-139 in Subjects With Advanced Solid Tumors [Phase 1]